Full
Outline
Chikungunya hemorrhagic fever（CHIK）is an acute infectious disease caused by the Chikungunya virus and transmitted by Aedes mosquitoes，primarily characterized by fever，rash and joint pain. Existing literature indicates that Yunnan and Fujian are regions with high incidence rates. The current outbreak in Shunde presents epidemiological and clinical features distinct from previous occurrences，reflecting the endemic characteristics commonly associated with diseases in the Lingnan region. Since the onset of the epidemic，the Shunde District Health Bureau and the Center for Disease Control and Prevention have jointly established an expert group dedicated to the diagnosis and treatment of CHIK using Traditional Chinese Medicine（TCM）. This expert group has conducted comprehensive analyses of syndrome elements during prevention，control and treatment processes at Lecong Hospital，Chencun Hospital and Beijiao Hospital，thereby accumulating substantial clinical evidence and practical experience. To standardize definitions，TCM disease nomenclature，syndrome differentiation，treatment protocols and efficacy evaluation criteria for this CHIK outbreak，and to enhance clinical management while improving patient prognosis and quality of life，the Chikungunya hemorrhagic fever TCM Treatment Expert Group has formulated a unified clinical treatment protocol addressing this critical issue. Drawing upon relevant domestic guidelines and integrating the actual clinical situation of CHIK cases in Shunde of Guangdong Province，the protocol has undergone revisions through the collaborative efforts of experts and now serves as a guiding document for the TCM-based diagnosis and treatment of CHIK in the Lingnan region. This treatment protocol is intended to assist physicians engaged in TCM emergency care in making appropriate clinical assessments and treatment decisions for patients with this acute infectious disease. It is designed solely as a reference for TCM practitioners in the diagnosis and treatment of CHIK and should be applied in conjunction with actual clinical circumstances.
23
9
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
